Single-chain antibodies for directed stem cell homing and targeting of effector cells in vascular disease

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/472667

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Regenerative cellular therapy e.g. with adult stem cells is a promising novel medical therapy. However, until now there is no reliable method to direct cells to areas where they are needed. We aim to develop a biotechnological approach based on genetically tailored antibody molecules that will allow cell targeting. As a pilot project we will test whether this approach improves lipid deposition and hardening of arteries.

Funded Activity Details

Start Date: 01-01-2008

End Date: 01-01-2010

Funding Scheme: NHMRC Project Grants

Funding Amount: $596,677.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Nutrigenomics and personalised nutrition

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

antibody | atherosclerosis | cardiovascular and other disease prevention | endothelial dysfunction during atherosclerosis | myocardial infarction | stem cell therapy | stem cells | therapeutics

Related Links